MARSTACIMAB-HNCQ

MARSTACIMAB-HNCQ was reported 103 times

These side effects are most commonly reported by patients taking MARSTACIMAB-HNCQ:

# Side effect Count
0 HAEMARTHROSIS 21
1 HAEMORRHAGE 18
2 DRUG DOSE OMISSION BY DEVICE 9
3 DEVICE DEFECTIVE 7
4 DEVICE FAILURE 6
5 EPISTAXIS 6
6 CONTUSION 5
7 ARTHRALGIA 4
8 DEVICE MALFUNCTION 4
9 DRUG INEFFECTIVE 4
10 JOINT SWELLING 4
11 PRODUCT DOSE OMISSION ISSUE 4
12 TRANSIENT ISCHAEMIC ATTACK 4
13 TRAUMATIC HAEMORRHAGE 4
14 DEVICE MECHANICAL ISSUE 3
15 FALL 3
16 SUSPECTED OFF LABEL USE 3
17 SWELLING 3
18 ALANINE AMINOTRANSFERASE INCREASED 2
19 ASPARTATE AMINOTRANSFERASE INCREASED 2
20 BLINDNESS UNILATERAL 2
21 BRAIN FOG 2
22 CHEST PAIN 2
23 DEVICE BREAKAGE 2
24 DEVICE DELIVERY SYSTEM ISSUE 2
25 DEVICE DEPLOYMENT ISSUE 2
26 DEVICE LEAKAGE 2
27 FRACTURE 2
28 HAEMATURIA 2
29 HYPOAESTHESIA 2
30 INJECTION SITE PAIN 2
31 INJECTION SITE SWELLING 2
32 INJURY 2
33 JOINT MICROHAEMORRHAGE 2
34 LIMB INJURY 2
35 LOWER LIMB FRACTURE 2
36 MUSCLE HAEMORRHAGE 2
37 MUSCLE SPASMS 2
38 NECK PAIN 2
39 NEPHROLITHIASIS 2
40 OFF LABEL USE 2
41 PAIN 2
42 PAIN IN EXTREMITY 2
43 SPONTANEOUS HAEMORRHAGE 2
44 URTICARIA 2
45 ABDOMINAL DISCOMFORT 1
46 ABDOMINAL PAIN 1
47 ABDOMINAL PAIN UPPER 1
48 ACCIDENTAL EXPOSURE TO PRODUCT 1
49 ACUTE KIDNEY INJURY 1
50 ACUTE MYOCARDIAL INFARCTION 1
51 ANAEMIA 1
52 ATRIAL FIBRILLATION 1
53 BLINDNESS 1
54 BLOOD POTASSIUM DECREASED 1
55 BLOOD PRESSURE INCREASED 1
56 BONE DISORDER 1
57 CENTRAL VENOUS CATHETER REMOVAL 1
58 CEREBRAL HAEMORRHAGE 1
59 CEREBROVASCULAR ACCIDENT 1
60 CONDITION AGGRAVATED 1
61 CONFUSIONAL STATE 1
62 DEEP VEIN THROMBOSIS 1
63 DEVICE OCCLUSION 1
64 DEVICE OPERATIONAL ISSUE 1
65 DEVICE PHYSICAL PROPERTY ISSUE 1
66 DIARRHOEA 1
67 DISTURBANCE IN ATTENTION 1
68 DIZZINESS 1
69 DYSARTHRIA 1
70 ERECTILE DYSFUNCTION 1
71 EXTRA DOSE ADMINISTERED 1
72 FATIGUE 1
73 FEELING ABNORMAL 1
74 FEELING HOT 1
75 FIBRIN D DIMER INCREASED 1
76 GASTROINTESTINAL DISORDER 1
77 GENERAL PHYSICAL HEALTH DETERIORATION 1
78 GINGIVAL BLEEDING 1
79 HAEMOPHILIA 1
80 HAEMORRHAGE URINARY TRACT 1
81 HEAD INJURY 1
82 HEADACHE 1
83 HOSPITALISATION 1
84 HYPERSENSITIVITY 1
85 IMPAIRED GASTRIC EMPTYING 1
86 INCORRECT DOSE ADMINISTERED 1
87 INCORRECT DOSE ADMINISTERED BY DEVICE 1
88 INFECTION 1
89 INFLUENZA 1
90 INJECTION SITE BRUISING 1
91 INJECTION SITE DISCHARGE 1
92 INJECTION SITE HAEMORRHAGE 1
93 INJECTION SITE HYPERSENSITIVITY 1
94 INJECTION SITE REACTION 1
95 INJURY ASSOCIATED WITH DEVICE 1
96 INTERMENSTRUAL BLEEDING 1
97 INTERNAL HAEMORRHAGE 1
98 KNEE OPERATION 1
99 MYOCARDIAL INFARCTION 1
100 NASOPHARYNGITIS 1
101 NEEDLE ISSUE 1
102 NO ADVERSE EVENT 1
103 OCCUPATIONAL EXPOSURE TO PRODUCT 1
104 PARAESTHESIA 1
105 PELVIC PAIN 1
106 PERIPROSTHETIC FRACTURE 1
107 POOR VENOUS ACCESS 1
108 PRODUCT USE ISSUE 1
109 PROTHROMBIN FRAGMENT 1.2 INCREASED 1
110 PRURITUS 1
111 SKIN HAEMORRHAGE 1
112 SKIN LACERATION 1
113 SLEEP TERROR 1
114 SOFT TISSUE HAEMORRHAGE 1
115 SPEECH DISORDER 1
116 THROAT TIGHTNESS 1
117 THROMBOTIC STROKE 1
118 TREATMENT FAILURE 1
119 TREMOR 1
120 TUNNEL VISION 1
121 UNDERDOSE 1
122 UPPER LIMB FRACTURE 1
123 URINARY TRACT INFECTION 1
124 VISION BLURRED 1
125 VISUAL IMPAIRMENT 1
126 VOMITING 1
127 WOUND INFECTION 1
128 WRIST SURGERY 1
129 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1